Effects of weekly one-hour hatha yoga therapy on resilience and stress levels in patients with schizophrenia-spectrum disorders: An eight-week randomized controlled trial

Journal of Alternative and Complementary Medicine

Volumn 20, Issue 11, 2014, Pages 823-830

  Ikai, Saeko ^a   Suzuki, Takefumi ^a,b   Uchida, Hiroyuki ^a,c   Saruta, Juri ^d   Tsukinoki, Keiichi ^d   Fujii, Yasuo ^e   Mimura, Masaru ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Inokashira Hospital   (Japan)

^c CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^d KANAGAWA DENTAL COLLEGE   (Japan)

^e Yamanashi Prefectural University   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA AMYLASE SALIVA ISOENZYME; BRAIN DERIVED NEUROTROPHIC FACTOR;

25 ITEM RESILIENCE SCALE; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COPING BEHAVIOR; DISEASE DURATION; ENZYME ACTIVITY; FEMALE; HUMAN; MALE; MIDDLE AGED; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PSYCHOLOGICAL RATING SCALE; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; SINGLE BLIND PROCEDURE; STRESS; TREATMENT DURATION; YOGA; ANALYSIS OF VARIANCE; MENTAL STRESS; PSYCHOLOGY; QUALITY OF LIFE; TREATMENT OUTCOME;

ADULT; ANALYSIS OF VARIANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; RESILIENCE, PSYCHOLOGICAL; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SINGLE-BLIND METHOD; STRESS, PSYCHOLOGICAL; TREATMENT OUTCOME; YOGA;

EID: 84927762452     PISSN: 10755535     EISSN: 15577708     Source Type: Journal    
DOI: 10.1089/acm.2014.0205     Document Type: Article

References (37)

1. Iyengar B. Light on Yoga. New York: Schocken Books, 1996.
2. Balasubramaniam M, Telles S, Doraiswamy PM. Yoga on our minds: a systematic review of yoga for neuropsychiatric disorders. Front Psychiatry 2012;3:117.
3. Behere RV, Arasappa R, Jagannathan A, et al. Effect of yoga therapy on facial emotion recognition deficits, symptoms and functioning in patients with schizophrenia. Acta Psychiatr Scand 2011;123:147-153.
4. Duraiswamy G, Thirthalli J, Nagendra HR, Gangadhar BN. Yoga therapy as an add-on treatment in the management of patients with schizophrenia-A randomized controlled trial. Acta Psychiatr Scand 2007;116:226-232.
5. Visceglia E, Lewis S. Yoga therapy as an adjunctive treatment for schizophrenia: a randomized, controlled pilot study. J Altern Complement Med 2011;17:601-607.
6. Xie J, Lin Y, Guo C, Chen F. Study of influences of yoga on quality of life of schizophrenic inpatients. J Nursing (China). 2006;13:9-11.
7. Cramer H, Lauche R, Klose P, et al. Yoga for schizophrenia: a systematic review and meta-Analysis. BMC Psychiatry. 2013;13:32.
8. Brown RP, Gerbarg PL. Yoga breathing, meditation, and longevity. Ann N Y Acad Sci. 2009;1172:54-62.
9. Chong CS, Tsunaka M, Tsang HW, et al. Effects of yoga on stress management in healthy adults: a systematic review. Altern Ther Health Med 2011;17:32-38.
10. Li AW, Goldsmith CA. The effects of yoga on anxiety and stress. Altern Med Rev 2012;17:21-35.
11. Howes OD, McDonald C, Cannon M, et al. Pathways to schizophrenia: the impact of environmental factors. Int J Neuropsychopharmacol 2004;7 Suppl 1:S7-S13.
12. Lutha SS, Cicchetti D. The construct of resilience: implications for interventions and social policies. Dev Psychopathol 2000;12:857-885.
13. Yagi K. [Resilience in mental disorders-special reference to biological research.] Seishin Shinkeigaku Zasshi 2008; 110:770-775.
14. Schumacher J, Leppert K, Gunzelmann T, et al. The resilience scale-A questionnaire to assess resilience as a personality characteristic. Z Klin Psychol Psychiatr Psychother 2005;53:16-39.
15. Torgalsboen AK. Sustaining full recovery in schizophrenia after 15 years: does resilience matter? Clin Schizophr Relat Psychoses 2012;5:193-200.
16. Malberg JE, Schechter LE. Increasing hippocampal neurogenesis: a novel mechanism for antidepressant drugs. Curr Pharm Des 2005;11:145-155.
17. Nater UM, Rohleder N. Salivary alpha-Amylase as a noninvasive biomarker for the sympathetic nervous system: current state of research. Psychoneuroendocrinology 2009; 34:486-496.
18. World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines. Geneva: World Health Organization, 1992.
19. Ikai S, Uchida H, Suzuki T, et al. Effects of yoga therapy on postural stability in patients with schizophreniaspectrum disorders: a single-blind randomized controlled trial. J Psychiatr Res 2013;47:1744-1750.
20. Ahern NR, Kiehl EM, Sole ML, Byers J. A review of instruments measuring resilience. Issues Compr Pediatr Nurs 2006;29:103-125.
21. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-276.
22. Inada T. [Evaluation and Diagnosis of Drug-Induced Extrapyramidal Symptoms: Commentary on the DIEPSS and Guide to Its Usage]. Tokyo: Seiwa Press, 1996.
23. Suzuki T, Uchida H, Nomura K, et al. Novel rating scales for schizophrenia-Targeted Inventory on Problems in Schizophrenia (TIP-Sz) and Functional Assessment for Comprehensive Treatment of Schizophrenia (FACT-Sz). Schizophr Res 2008;106:328-336.
24. Brooks R. EuroQol: the current state of play. Health Pol 1996;37:53-72.
25. Inagaki A, Inada T, Fujii Y. [Dose Equivalents of Psychotropic Drugs]. Tokyo: Seiwa Press, 1999.
26. Inagaki A, Inada T. [Dose equivalence of psychotropic drugs. Part XXI: dose equivalence of novel antipsychotics.] Jpn J Clin Psychopharmacol 2008;11:887-890.
27. Shetty V, Zigler C, Robles TF, et al. Developmental validation of a point-of-care, salivary alpha-Amylase biosensor. Psychoneuroendocrinology 2011;36:193-199.
28. Vancampfort D, De Hert M, Knapen J, et al. State anxiety, psychological stress and positive well-being responses to yoga and aerobic exercise in people with schizophrenia: a pilot study. Disabil Rehabil 2011;33:684-689.
29. Khalsa SB, Hickey-Schultz L, Cohen D, et al. Evaluation of the mental health benefits of yoga in a secondary school: a preliminary randomized controlled trial. J Behav Health Serv Res 2012;39:80-90.
30. Noggle JJ, Steiner NJ, Minami T, Khalsa SB. Benefits of yoga for psychosocial well-being in a US high school curriculum: a preliminary randomized controlled trial. J Dev Behav Pediatr 2012;33:193-201.
31. Michalsen A, Grossman P, Acil A, et al. Rapid stress reduction and anxiolysis among distressed women as a consequence of a three-month intensive yoga program. Med Sci Monit 2005;11:CR555-561.
32. Gururaja D, Harano K, Toyotake I, Kobayashi H. Effect of yoga on mental health: comparative study between young and senior subjects in Japan. Int J Yoga 2011;4: 7-12.
33. Ieda M, Miyaoka T, Wake R, et al. Evaluation of autonomic nervous system by salivary alpha-Amylase level and heart rate variability in patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci 2014;264:83-87.
34. Green MJ, Matheson SL, Shepherd A, et al. Brain-derived neurotrophic factor levels in schizophrenia: a systematic review with meta-Analysis. Mol Psychiatry 2011;16:960-972.
35. Pan NL LC, Jiang MJ, HP Lu, CL Wang, AM Huang. Serum levels of brain derived neurotrophic factor before and after the practice of Sudarshan Kriya. Proceedings World Conference Expanding Paradigms: Science, Consciousness and Spirituality. New Delhi, India: All India Institute of Medical Sciences. 2006:156-160.
36. Naveen GH, Thirthalli J, Rao MG, et al. Positive therapeutic and neurotropic effects of yoga in depression: a comparative study. Ind J Psychiatry 2013;55(Suppl 3): S400-404.
37. Favalli G, Li J, Belmonte-de-Abreu P, et al. The role of BDNF in the pathophysiology and treatment of schizophrenia. J Psychiatr Res 2012;46:1-11.